Cellcept and Venous thrombosis limb - a phase IV clinical study of FDA data

Summary:

Venous thrombosis limb is reported as a side effect among people who take Cellcept (mycophenolate mofetil), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Prograf, and have Cytomegalovirus infection.

The phase IV clinical study analyzes which people have Venous thrombosis limb when taking Cellcept. It is created by eHealthMe based on reports of 41,092 people who have side effects when taking Cellcept from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Venous thrombosis limb?

Venous thrombosis limb (blood clot that forms in a vein in the limb) is found to be associated with 365 drugs and 502 conditions by eHealthMe. Check the latest studies of Venous thrombosis limb.

On Jul, 31, 2026

41,092 people reported to have side effects when taking Cellcept.
Among them, 22 people (0.05%) have Venous thrombosis limb.

Could Cellcept cause Venous thrombosis limb?

Among these 22 people:

How long have people been on Cellcept when they have Venous thrombosis limb? *

What is the gender of people who have Venous thrombosis limb when taking Cellcept? *

female: 23.81 %
male: 76.19 %

What is the age of people who have Venous thrombosis limb when taking Cellcept? *

What are other drugs people take besides Cellcept? *

What are other side effects people have besides Venous thrombosis limb? *

Hepatic Function Abnormal: 6 people, 27.27%
Pulmonary Embolism (blockage of the main artery of the lung): 5 people, 22.73%
Pulmonary Nocardiosis (lung infection by inhalation of nocardia spores): 5 people, 22.73%
Blood Creatinine Increased: 4 people, 18.18%
Hypokalemia (low potassium): 4 people, 18.18%
Chills (felling of cold): 3 people, 13.64%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 3 people, 13.64%
Pulmonary Infarction (death of a small area of lung): 3 people, 13.64%
Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 3 people, 13.64%
Idiopathic Or Primary Livedo Reticularis (netlike pattern of reddish-blue skin discoloration, usually on the legs): 3 people, 13.64%

What are the existing conditions these people have? *

Cytomegalovirus Infection: 6 people, 27.27%
High Blood Pressure: 3 people, 13.64%
Pulmonary Nocardiosis (lung infection by inhalation of nocardia spores): 2 people, 9.09%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 2 people, 9.09%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 4.55%
Nephrogenic Anaemia (anaemia due to kidney disease): 1 person, 4.55%
Joint Pain: 1 person, 4.55%
Immunodeficiency Disorders: 1 person, 4.55%
Epstein-Barr Virus Infection: 1 person, 4.55%
Cytomegalovirus Test Positive: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and have Venous thrombosis limb?

- Check whether Venous thrombosis limb is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cellcept:

Cellcept (41,872 reports)

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Venous thrombosis limb:

Venous thrombosis limb (365 drugs)

Browse all the conditions that are associated with Venous thrombosis limb:

Venous thrombosis limb (502 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Cellcept) and Cellcept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.